Switzerland Compensates Two for COVID Jab Injuries as Hundreds of Claims Pending

Five years after Switzerland launched its massive vaccination campaign against Covid-19, the government has finally confirmed the scale of compensation for vaccine-related injuries, and the numbers are stark. Out of a staggering 408 applications filed by citizens claiming harm, authorities have granted compensation in a mere two cases. This revelation exposes a massive disparity between the volume of grievances and the government's validation of those claims.

While millions of Swiss residents rolled up their sleeves starting in December 2020, the aftermath has left a subset of the population grappling with health complications they attribute to the jab. As of early 2026, the Interior Ministry has processed 300 of these claims. The fact that only two individuals have successfully navigated the rigorous approval process highlights an exceptionally high threshold for proof and liability. This is not just a statistical anomaly; it represents a significant hurdle for hundreds of claimants who remain in limbo or have faced rejection. The government stands firm on its rigorous assessment protocols, but for the 406 applicants who have yet to see a franc, the silence is deafening.

The financial figures attached to these rare approvals paint a modest picture of state reparations. The first breakthrough came in 2024, when a single claimant was awarded CHF 13,860 ($18,000) for damages proven to be a direct result of the Covid-19 vaccination. This precedent-setting payment remained the sole instance of compensation for over a year, underscoring the rarity of such rulings.

In July 2025, a second case finally cleared the bureaucratic hurdles. A spokeswoman for the Interior Ministry confirmed to Keystone-SDA that this individual received CHF 6,000. Under the Swiss Epidemics Act, these payments are not solely a federal burden; cantons are also mandated to contribute to these reparations. However, with the total payout across five years amounting to less than CHF 20,000 combined, the financial impact on the state is negligible compared to the billions spent on vaccine procurement and distribution. For the victims, however, these sums represent the only official acknowledgement of their suffering.

Claimants are facing a grueling test of patience, with the administrative machinery moving at a glacial pace. The Interior Ministry has revealed that the successful awards were granted only after approximately three years from the date of application. This timeline suggests that individuals filing claims today may not see a resolution until the late 2020s.

With 300 cases processed and over 100 still pending review, the backlog is significant. The rigorous investigation required to prove a causal link between the vaccine and specific health injuries is undoubtedly complex, yet the three-year lag time places an immense emotional and financial strain on applicants. As new applications continue to arrive on an ongoing basis, the system risks becoming further clogged. The disparity between the rapid rollout of the vaccine in 2020 and the slow-motion processing of injury claims creates a tension that the government will likely have to address as public scrutiny intensifies.

As Switzerland moves deeper into 2026, the narrative surrounding the pandemic response is shifting from crisis management to accountability. The government has already completely revised its pandemic plan in light of lessons learned from Covid-19, but the chapter on vaccine injuries remains wide open. The 108 pending applications represent over a hundred citizens still waiting for an answer, and with new claims still being filed, this issue is far from resolved.

The extremely low success rate—two wins out of 300 attempts—sets a daunting precedent for future applicants. It signals that while the Swiss state acknowledges the possibility of vaccine injury, the bar for proving it is set sky-high. As the Federal Office of Public Health and the Interior Ministry continue to navigate these choppy waters, the pressure will be on to ensure that the process is not just rigorous, but also fair and timely. For now, the data tells a clear story: compensation is possible, but it is exceptionally rare.